Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing a pontetial of drugs

Toxicological Sciences

Volumn 79, Issue 1, 2004, Pages 90-97

  Nierkens, Stefan ^a   Nieuwenhuijsen, Leonie ^a   Thomas, Mieke ^a   Pieters, Raymond ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN CLASS; INTERLEUKIN 1BETA; METFORMIN; OFLOXACIN; PENICILLAMINE; PHENOBARBITAL; PHENYTOIN; PROCAINAMIDE; RADIOISOTOPE; STREPTOZOCIN; SULFAMETHOXAZOLE; TUMOR NECROSIS FACTOR ALPHA;

ADVERSE DRUG REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DETERMINATION; DRUG HYPERSENSITIVITY; DRUG SCREENING; DRUG SENSITIZATION; ETHICS; EVALUATION; FEMALE; FOOT PAD; IMMUNOGENICITY; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; SCREENING TEST; SUPPRESSOR CELL;

ANIMALS; ANTIGENS; B-LYMPHOCYTES; DRUG EVALUATION, PRECLINICAL; EAR, EXTERNAL; FEMALE; FICOLL; IMMUNIZATION; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRADERMAL; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE I; INTERFERON TYPE II; LOCAL LYMPH NODE ASSAY; LYMPH NODES; MICE; MICE, INBRED BALB C; OFLOXACIN; OVALBUMIN; PHENYTOIN; SULFAMETHOXAZOLE; T-LYMPHOCYTES;

EID: 2442674125     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh074     Document Type: Article

References (31)

1. Adkinson, N. F., Jr., Essayan, D., Gruchalla, R., Haggerty, H., Kawabata, T., Sandler, J. D., Updyke, L., Shear, N. H., and Wierda, D. (2002). Task force report: Future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J. Allergy Clin. Immunol. 109, S461-S478.
2. Alarcón-Segovia, D., and Alarcón-Riquelme, M. (1989). Autoimmune reactions in humans induced by diphenylhydantoin and nitrofurantoin. In Auto-immunity and Toxicology (M. E. Kammüller, N. Bloksma, and W. Seinen, Eds.), pp. 149-166. Elsevier Science Publishers BV (Biomedical Division), Amsterdam.
3. Albers, R., Broeders, A., van der Pijl, A., Seinen, W., and Pieters, R. (1997). The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals. Toxicol. Appl. Pharmacol. 143, 102-109.
4. Albers, R., van der Pijl, A., Seinen, W., Pieters, R., and Bloksma, N. (1996). The autoimmunogenic chemicals HgCl2 and diphenylhydantoin stimulate IgG production to TNP-Ficoll and TNP-OVA, supporting and extending the graft-versus-host hypothesis for chemical induction of autoimmunity. Immunology 89, 468-473.
5. Ashby, J., Hilton, J., Dearman, R. J., and Kimber, I, (1995). Streptozotocin: Inherent but not expressed skin sensitizing activity. Contact Dermatitis 33, 165-167.
6. Baron, J. M., and Merk, H. F. (2001). Drug metabolism in the skin. Curr. Opin. Allergy Clin. Immunol. 1, 287-291.
7. Bloksma, N., Kubicka-Muranyi, M., Schuppe, H. C., Gleichmann, E., and Gleichmann, H. (1995). Predictive immunotoxicological test systems: Suitability of the popliteal lymph node assay in mice and rats. Crit. Rev. Toxicol. 25, 369-396.
8. Dean, J. H. (2000). The nature and importance of drug allergy. Toxicology 148, 11-12 (abstract).
9. De Bakker, J. M., Kammüller, M. E., Muller, E. S., Lam, A. W., Seinen, W., and Bloksma, N. (1990). Kinetics and morphology of chemically induced popliteal lymph node reactions compared with antigen-, mitogen-, and graft-versus-host-reaction-induced responses. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 58, 279-287.
10. Emery, P., and Panayi, G. (1989). Autoinumme, reactions to D-penicillamine. In Autoimmunity and Toxicology (M. E. Kammüller, N. Bloksma, and W. Seinen, Eds.), pp. 167-182. Elsevier Science Publishers BV (Biomedical Division), Amsterdam.
11. Gerberick, G. F., Cruse, L. W., Ryan, C. A., Hulette, B. C., Chaney, J. G., Skinner, R. A., Dearman, R. J., and Kimber, I. (2002). Use of a B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay. Toxicol. Sci. 68, 420-428.
12. Gleichmann, E., and Gleichmann, H. (1976). Graft-versus-host reaction: A pathogenetic principle for the development of drug allergy, autoimmunity, and malignant lymphoma in non-chimeric individuals. Hypothesis. Z Krebsforsch. Klin. Onkol. Cancer Res. Clin. Oncol. 85, 91-109.
13. Gutting, B. W., Updyke, L. W., and Amacher, D. E. (2002). Diclofenac activates T cells in the direct popliteal lymph node assay and selectively induces IgG(1) and IgE against co-injected TNP-OVA. Toxicol. Lett. 131, 167-180.
14. Hashizume, H., Takigawa, M., and Tokura, Y. (2002). Characterization of drug-specific T cells in phenobarbital-induced eruption. J. Immunol. 168, 5359-5368.
15. Kammüller, M. E., Thomas, C., De Bakker, J. M., Bloksma, N., and Seinen, W. (1989). The popliteal lymph node assay in mice to screen for the immune disregulating potential of chemicals - a preliminary study. Int. J. Immunopharmacol. 11, 293-300.
16. Katsutani, N., and Shionoya, H. (1992). Popliteal lymph node enlargement induced by procainamide. Int. J. Immunopharmacol. 14, 681-686.
17. Kimber, I., Dearman, R. J., Basketter, D. A., Ryan, C. A., and Gerberick, G. F. (2002). The local lymph node assay: Past, present, and future. Contact Dermatitis 47, 315-328.
18. Kubicka-Muranyi, M., Goebels, R., Goebel, C., Uetrecht, J., and Gleichmann, E. (1993). T lymphocytes ignore procainamide, but respond to its reactive metabolites in peritoneal cells: Demonstration by the adoptive transfer popliteal lymph node assay. Toxicol. Appl. Pharmacol. 122, 88-94.
19. Lukic, M. L., Stosic-Grujicic, S., and Shahin, A. (1998). Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev. Immunol. 6, 119-128.
20. Luster, M. I., Simeonova, P. P., Gallucci, R., and Matheson, J. (1999). Autoimmunity and risk assessment. Environ. Health Perspect. 107, 679-680.
21. Manetz, T. S., and Meade, B. J. (1999). Development of a flow cytometry assay for the identification and differentiation of chemicals with the potential to elicit irritation, IgE-mediated, or T cell-mediated hypersensitivity responses. Toxicol. Sci. 48, 206-217.
22. Matzinger, P. (2002). The danger model: A renewed sense of self. Science 296, 301-305.
23. Melde, S. L. (2001). Ofloxacin: A probable cause of toxic epidermal necrolysis. Ann. Pharmacother. 35, 1388-1390.
24. Nierkens, S., van Helden, P., Bol, M., Bleumink, R., van Kooten, P., Ramdien-Murli, S., Boon, L., and Pieters, R. (2002). Selective requirement for CD40-CD154 in drug-induced type 1 versus type 2 responses to trinitrophenyl-ovalbumin. J. Immunol. 168, 3747-3754.
25. Pieters, R., and Albers, R. (1999). Screening tests for autoimmune-related immunotoxicity. Environ. Health Perspect. 107, 673-677.
26. Pirmohamed, M., Naisbitt, D. J., Gordon, F., and Park, B. K. (2002). The danger hypothesis - potential role in idiosyncratic drug reactions. Toxicology 181-182, 55-63.
27. Rossini, A. A., Appel, M. C., Williams, R. M., and Like, A. A. (1977). Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes 26, 916-920.
28. Schielen, P., van Rodijnen, W., Tekstra, J., Albers, R., and Seinen, W. (1995). Quantification of natural antibody producing B cells in rats by an improved ELISPOT technique using the polyvinylidene difluoride membrane as the solid support. J. Immunol. Methods 188, 33-41.
29. Takayama, K., Yokozeki, H., Ghoreishi, M., Satoh, T., Katayama, I., Umeda, T., and Nishioka, K. (1999). IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression. J. Invest. Dermatol. 113, 541-546.
30. Uetrecht, J. (1990). Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions. Crit. Rev. Toxicol. 20, 213-235.
31. Wulferink, M., Gonzalez, J., Goebel, C., and Gleichmann, E. (2001). T cells ignore aniline, a prohapten, but respond to its reactive metabolites generated by phagocytes: Possible implications for the pathogenesis of toxic oil syndrome. Chem. Res. Toxicol. 14, 389-397.